{"id":"https://openalex.org/W1966256648","doi":"https://doi.org/10.1002/syn.890050202","title":"Nigrostriatal lesion alters neurophysiological responses to selective and nonselective D\u20101 and D\u20102 dopamine agonists in rat globus pallidus","display_name":"Nigrostriatal lesion alters neurophysiological responses to selective and nonselective D\u20101 and D\u20102 dopamine agonists in rat globus pallidus","publication_year":1990,"publication_date":"1990-01-01","ids":{"openalex":"https://openalex.org/W1966256648","doi":"https://doi.org/10.1002/syn.890050202","mag":"1966256648","pmid":"https://pubmed.ncbi.nlm.nih.gov/2309160"},"language":"en","primary_location":{"id":"doi:10.1002/syn.890050202","doi":"https://doi.org/10.1002/syn.890050202","is_oa":false,"landing_page_url":"https://doi.org/10.1002/syn.890050202","pdf_url":null,"source":{"id":"https://openalex.org/S158211696","display_name":"Synapse","issn_l":"0887-4476","issn":["0887-4476","1098-2396"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Synapse","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5057997963","display_name":"Joanne H. Carlson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I193531525","display_name":"George Washington University","ror":"https://ror.org/00y4zzh67","country_code":"US","type":"education","lineage":["https://openalex.org/I193531525"]},{"id":"https://openalex.org/I4210110767","display_name":"National Institute of Neurological Disorders and Stroke","ror":"https://ror.org/01s5ya894","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210110767"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joanne H. Carlson","raw_affiliation_strings":["Physiological Neuropharmacology Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892","Department of Pharmacology, The George Washington University, Washington, D.C. 20037","Physiological Neuropharmacology Section, Experimental Therapeutics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Physiological Neuropharmacology Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210110767"]},{"raw_affiliation_string":"Department of Pharmacology, The George Washington University, Washington, D.C. 20037","institution_ids":["https://openalex.org/I193531525"]},{"raw_affiliation_string":"Physiological Neuropharmacology Section, Experimental Therapeutics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210110767"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042611495","display_name":"Debra A. Bergstrom","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210110767","display_name":"National Institute of Neurological Disorders and Stroke","ror":"https://ror.org/01s5ya894","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210110767"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Debra A. Bergstrom","raw_affiliation_strings":["Physiological Neuropharmacology Section, Experimental Therapeutics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Physiological Neuropharmacology Section, Experimental Therapeutics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210110767"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013905850","display_name":"Susan D. Demo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210110767","display_name":"National Institute of Neurological Disorders and Stroke","ror":"https://ror.org/01s5ya894","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210110767"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Susan D. Demo","raw_affiliation_strings":["Physiological Neuropharmacology Section, Experimental Therapeutics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Physiological Neuropharmacology Section, Experimental Therapeutics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210110767"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5034511392","display_name":"Judith R. Walters","orcid":"https://orcid.org/0000-0002-9192-5222","observed_orcids":["https://orcid.org/0000-0002-9192-5222"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210110767","display_name":"National Institute of Neurological Disorders and Stroke","ror":"https://ror.org/01s5ya894","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210110767"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Judith R. Walters","raw_affiliation_strings":["Physiological Neuropharmacology Section, Experimental Therapeutics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Physiological Neuropharmacology Section, Experimental Therapeutics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210110767"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3570,"currency":"USD","value_usd":3570},"apc_paid":null,"fwci":3.6208,"has_fulltext":false,"cited_by_count":44,"citation_normalized_percentile":{"value":0.92623799,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"5","issue":"2","first_page":"83","last_page":"93"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10919","display_name":"Neurological disorders and treatments","score":0.7728999853134155,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10919","display_name":"Neurological disorders and treatments","score":0.7728999853134155,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.15369999408721924,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.03449999913573265,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nigrostriatal-lesion","display_name":"nigrostriatal lesion","score":0.7440000176429749},{"id":"https://openalex.org/keywords/globus-pallidus","display_name":"globus pallidus","score":0.8640000224113464},{"id":"https://openalex.org/keywords/dopamine-d1-receptor","display_name":"dopamine D1 receptor","score":0.6389999985694885},{"id":"https://openalex.org/keywords/dopamine-d2-receptor","display_name":"dopamine D2 receptor","score":0.9990000128746033},{"id":"https://openalex.org/keywords/dopamine-agonists","display_name":"dopamine agonists","score":0.7070000171661377},{"id":"https://openalex.org/keywords/apomorphine","display_name":"apomorphine","score":0.8560000061988831},{"id":"https://openalex.org/keywords/quinpirole","display_name":"quinpirole","score":0.9490000009536743},{"id":"https://openalex.org/keywords/skf-38393","display_name":"SKF 38393","score":0.9959999918937683},{"id":"https://openalex.org/keywords/6-ohda-lesion","display_name":"6-hydroxydopamine lesion","score":0.9430000185966492},{"id":"https://openalex.org/keywords/spontaneous-neuronal-activity","display_name":"spontaneous neuronal activity","score":0.6309999823570251},{"id":"https://openalex.org/keywords/spiperone","display_name":"spiperone","score":0.8759999871253967},{"id":"https://openalex.org/keywords/dopamine-receptor-antagonists","display_name":"dopamine antagonists","score":0.5720000267028809},{"id":"https://openalex.org/keywords/basal-ganglia","display_name":"basal ganglia","score":0.8270000219345093}],"concepts":[{"id":"https://openalex.org/C2778296116","wikidata":"https://www.wikidata.org/wiki/Q253187","display_name":"Quinpirole","level":4,"score":0.924815833568573},{"id":"https://openalex.org/C2777525119","wikidata":"https://www.wikidata.org/wiki/Q269111","display_name":"Apomorphine","level":4,"score":0.7954603433609009},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.7306649684906006},{"id":"https://openalex.org/C2780278869","wikidata":"https://www.wikidata.org/wiki/Q1759633","display_name":"Globus pallidus","level":4,"score":0.7249450087547302},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.6719786524772644},{"id":"https://openalex.org/C2776355744","wikidata":"https://www.wikidata.org/wiki/Q4318555","display_name":"Nigrostriatal pathway","level":5,"score":0.6658790111541748},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6487986445426941},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5951821804046631},{"id":"https://openalex.org/C2778258207","wikidata":"https://www.wikidata.org/wiki/Q600203","display_name":"Dopamine agonist","level":4,"score":0.5488728284835815},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.48529571294784546},{"id":"https://openalex.org/C2781353949","wikidata":"https://www.wikidata.org/wiki/Q3271533","display_name":"Dopamine antagonist","level":4,"score":0.4778696894645691},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.44324877858161926},{"id":"https://openalex.org/C2777288102","wikidata":"https://www.wikidata.org/wiki/Q780181","display_name":"Oxidopamine","level":5,"score":0.44140610098838806},{"id":"https://openalex.org/C120069818","wikidata":"https://www.wikidata.org/wiki/Q415496","display_name":"Dopamine receptor","level":3,"score":0.38720259070396423},{"id":"https://openalex.org/C137183658","wikidata":"https://www.wikidata.org/wiki/Q461076","display_name":"Dopaminergic","level":3,"score":0.32452887296676636},{"id":"https://openalex.org/C2780948584","wikidata":"https://www.wikidata.org/wiki/Q251347","display_name":"Haloperidol","level":3,"score":0.2333243489265442},{"id":"https://openalex.org/C2778187257","wikidata":"https://www.wikidata.org/wiki/Q464210","display_name":"Basal ganglia","level":3,"score":0.22834768891334534},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.1878359615802765},{"id":"https://openalex.org/C529278444","wikidata":"https://www.wikidata.org/wiki/Q47273","display_name":"Central nervous system","level":2,"score":0.18615469336509705},{"id":"https://openalex.org/C2780938664","wikidata":"https://www.wikidata.org/wiki/Q753278","display_name":"Substantia nigra","level":4,"score":0.1543058156967163},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.11293134093284607}],"mesh":[{"descriptor_ui":"D000200","descriptor_name":"Action Potentials","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001058","descriptor_name":"Apomorphine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D003342","descriptor_name":"Corpus Striatum","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003342","descriptor_name":"Corpus Striatum","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D004873","descriptor_name":"Ergolines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D005917","descriptor_name":"Globus Pallidus","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D005917","descriptor_name":"Globus Pallidus","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011919","descriptor_name":"Rats, Inbred Strains","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011954","descriptor_name":"Receptors, Dopamine","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D011954","descriptor_name":"Receptors, Dopamine","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D013378","descriptor_name":"Substantia Nigra","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D013378","descriptor_name":"Substantia Nigra","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D015647","descriptor_name":"2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D019257","descriptor_name":"Quinpirole","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1002/syn.890050202","doi":"https://doi.org/10.1002/syn.890050202","is_oa":false,"landing_page_url":"https://doi.org/10.1002/syn.890050202","pdf_url":null,"source":{"id":"https://openalex.org/S158211696","display_name":"Synapse","issn_l":"0887-4476","issn":["0887-4476","1098-2396"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Synapse","raw_type":"journal-article"},{"id":"pmid:2309160","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2309160","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Synapse (New York, N.Y.)","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.8371999859809875,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":46,"referenced_works":["https://openalex.org/W15234906","https://openalex.org/W586370793","https://openalex.org/W1590565925","https://openalex.org/W1917378969","https://openalex.org/W1960975817","https://openalex.org/W1966176551","https://openalex.org/W1966308411","https://openalex.org/W1966577272","https://openalex.org/W1970569351","https://openalex.org/W1973512436","https://openalex.org/W1980884630","https://openalex.org/W1981609060","https://openalex.org/W1982176417","https://openalex.org/W1988619576","https://openalex.org/W1989193138","https://openalex.org/W1993578402","https://openalex.org/W1994769900","https://openalex.org/W2003116007","https://openalex.org/W2006555465","https://openalex.org/W2017949567","https://openalex.org/W2021683549","https://openalex.org/W2024342346","https://openalex.org/W2028050703","https://openalex.org/W2039035354","https://openalex.org/W2041013190","https://openalex.org/W2043393596","https://openalex.org/W2044066882","https://openalex.org/W2051536308","https://openalex.org/W2057788173","https://openalex.org/W2060790782","https://openalex.org/W2062359923","https://openalex.org/W2063628608","https://openalex.org/W2063828160","https://openalex.org/W2072740414","https://openalex.org/W2074040480","https://openalex.org/W2083948707","https://openalex.org/W2088136957","https://openalex.org/W2088878456","https://openalex.org/W2091813848","https://openalex.org/W2094750156","https://openalex.org/W2164975184","https://openalex.org/W2168823834","https://openalex.org/W2269399726","https://openalex.org/W2340958497","https://openalex.org/W2410648369","https://openalex.org/W2420549516"],"related_works":["https://openalex.org/W2051536308","https://openalex.org/W2021683549","https://openalex.org/W2085689094","https://openalex.org/W2088878456","https://openalex.org/W2255081356","https://openalex.org/W2007883305","https://openalex.org/W2210895667","https://openalex.org/W2088804331","https://openalex.org/W2087294379","https://openalex.org/W2016487211"],"abstract_inverted_index":{"The":[0,225,259],"effects":[1,169,282],"of":[2,24,41,64,104,108,191,207,246,255,261,286,338,346],"the":[3,10,16,42,62,101,113,128,136,171,177,204,247,252,287,313,318,330,339,347],"selective":[4,11,348],"D-1":[5,129,248],"dopamine":[6,226,315,341],"agonist":[7,13,19,180,249,349],"SKF":[8,49,83,93],"38393,":[9],"D-2":[12,137],"quinpirole,":[14],"and":[15,34,52,98,152,218],"nonselective":[17,178],"D-1/D-2":[18,179],"apomorphine":[20,181,223,265],"on":[21,112],"spontaneous":[22],"activity":[23,63],"globus":[25,65,253],"pallidus":[26,66,254],"neurons":[27,211],"were":[28,124,212,216,220],"compared":[29],"in":[30,61,77,100,117,148,157,170,188,194,200,251,293,297,307,333],"normal":[31],"control":[32],"rats":[33,35,308],"with":[36,88,269,309],"unilateral":[37,89,310],"6-hydroxydopamine":[38,90],"induced":[39,91],"lesions":[40],"nigrostriatal":[43,158,201,311],"pathway.":[44],"In":[45,86,198,236],"control,":[46,118,149,195,298],"unlesioned":[47,119,150,196,299],"rats,":[48,203],"38393":[50,84,94],"(0.4":[51],"10":[53,81],"mg/kg,":[54,142,183],"i.v.)":[55,143,184],"caused":[56,95],"no":[57,327],"significant":[58,73],"net":[59],"change":[60,262],"neurons,":[67],"although":[68],"some":[69,208,219],"individual":[70],"cells":[71,110,193],"showed":[72],"increases":[74,97,147,156,187],"or":[75,317],"decreases":[76,99],"discharge":[78,102,189,205],"rates":[79,103,190,206],"following":[80,222],"mg/kg":[82],"administration.":[85,224],"animals":[87,151],"lesions,":[92,312],"greater":[96],"a":[105,278],"larger":[106,154],"percentage":[107],"pallidal":[109,192,210],"recorded":[111],"ipsilateral":[114,209],"side":[115],"than":[116],"animals.":[120,160,173,258,300],"These":[121],"rate":[122,146,155,234],"changes":[123],"effectively":[125,166],"reversed":[126,167,232],"by":[127,135,284],"antagonist":[130,138,227],"SCH":[131,164],"23390,":[132,165],"but":[133,162],"not":[134,163],"YM-09151-2.":[139],"Quinpirole":[140],"(0.3":[141,182],"produced":[144,185],"modest":[145],"significantly":[153],"lesioned":[159,172,202,257],"YM-09151-2,":[161],"quinpirole's":[168],"As":[174],"previously":[175],"reported,":[176],"large":[186],"rats.":[197],"contrast,":[199],"markedly":[213],"increased,":[214],"others":[215],"decreased,":[217],"unaffected":[221],"spiroperidol":[228],"partially":[229],"to":[230,242],"fully":[231],"these":[233,256,294,302],"changes.":[235],"summary,":[237],"apomorphine's":[238],"neurophysiological":[239],"profile":[240,250],"appears":[241],"be":[243],"an":[244],"exaggeration":[245],"degree":[260],"observed":[263],"after":[264],"administration":[266],"is":[267],"consistent":[268],"results":[270,303],"from":[271],"other":[272],"studies":[273],"that":[274,277,306,325],"have":[275,329],"indicated":[276],"synergistic":[279],"interaction":[280],"between":[281],"triggered":[283],"stimulation":[285,337],"two":[288],"receptor":[289,342],"subtypes":[290],"can":[291],"occur":[292],"animals,":[295],"as":[296],"However,":[301],"further":[304],"show":[305],"denervated":[314],"receptors":[316],"processes":[319],"they":[320,326],"mediate":[321],"are":[322],"altered":[323],"so":[324],"longer":[328],"requirement":[331],"seen":[332],"controls":[334],"for":[335,344],"concurrent":[336],"complementary":[340],"subtype":[343],"expression":[345],"effects.":[350]},"counts_by_year":[{"year":2014,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}